AU3222893A - Therapeutic composition and method for preventing reperfusion injury - Google Patents

Therapeutic composition and method for preventing reperfusion injury

Info

Publication number
AU3222893A
AU3222893A AU32228/93A AU3222893A AU3222893A AU 3222893 A AU3222893 A AU 3222893A AU 32228/93 A AU32228/93 A AU 32228/93A AU 3222893 A AU3222893 A AU 3222893A AU 3222893 A AU3222893 A AU 3222893A
Authority
AU
Australia
Prior art keywords
therapeutic composition
reperfusion injury
preventing reperfusion
preventing
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32228/93A
Inventor
Donald E Hultquist
Marshal Shlafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of AU3222893A publication Critical patent/AU3222893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32228/93A 1991-11-25 1992-11-24 Therapeutic composition and method for preventing reperfusion injury Abandoned AU3222893A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79771091A 1991-11-25 1991-11-25
US797710 1991-11-25
US96095892A 1992-10-14 1992-10-14
US960958 1992-10-14

Publications (1)

Publication Number Publication Date
AU3222893A true AU3222893A (en) 1993-06-28

Family

ID=27121920

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32228/93A Abandoned AU3222893A (en) 1991-11-25 1992-11-24 Therapeutic composition and method for preventing reperfusion injury

Country Status (2)

Country Link
AU (1) AU3222893A (en)
WO (1) WO1993010784A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321558D0 (en) * 1993-10-19 1993-12-08 Radopath Ltd Anti-viral agents
GB2319474A (en) * 1993-10-19 1998-05-27 Radopath Ltd Anti-viral agents
KR20010069066A (en) * 2000-01-12 2001-07-23 이종원 Culturing Method Which Allows Growth of Animal Cells Under Hypoxic Condition
US7276514B2 (en) 2002-05-15 2007-10-02 Charitable Leadership Foundation - Medical Technology Acceleration Program Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
CN101443010A (en) * 2006-04-10 2009-05-27 三菱瓦斯化学株式会社 Brain function-improving agent, and functional food containing the improving agent
EP3090738A1 (en) * 2015-05-04 2016-11-09 Universidade de Santiago de Compostela Riboflavin for the treatment of ischemic stroke and/or other glutamate excitotoxicity-associated diseases
JP2018131410A (en) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 Caspase-3 inhibitor and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302275C (en) * 1986-08-07 1992-06-02 Yuji Narutomi Enzyme inhibitor
EP0256472A3 (en) * 1986-08-11 1988-09-07 Lion Corporation Cosmetic agent for application to skin
US5080886A (en) * 1990-01-05 1992-01-14 Sterling Drug Inc. Pharmaceutical compositions for the prevention and treatment of oxidant injuries

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof

Also Published As

Publication number Publication date
WO1993010784A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
AU1110192A (en) Method and composition for treating reperfusion injury
AU2187992A (en) Composition and method for disease treatment
AU4861493A (en) Clear leave-on treatment composition and method
AP9100258A0 (en) Synergistic therapeutic compositions and methods
HU9400190D0 (en) Therapeutic compositions and methods
EP0656791A4 (en) Therapeutic compositions and methods using pqq.
AU1912992A (en) Method for treating hypothermia
AU1582992A (en) Milling process and apparatus
AU3222893A (en) Therapeutic composition and method for preventing reperfusion injury
AU1888692A (en) Composition and method for treating tumors
AU3011692A (en) Horseshoes and method for their preparation
AU3593793A (en) Putting and chipping apparatus
AU5264893A (en) Method for minimizing and containing ischemic and reperfusion injury
AU8513191A (en) Composition and method for protecting the heart during reperfusion
GB9315275D0 (en) Formulation for treating silage
HU9600067D0 (en) Pharmaceutical composition for immunomodulating and adjuvant treatment
GB9224295D0 (en) Method and composition
EP0522558A3 (en) Process for stabilizing dibenzylidenesorbitols and composition thereof
AU4860890A (en) Composable protection and control apparatus for motors
AU1850292A (en) Game and game apparatus
AU3682793A (en) Therapeutic preparation and method
BG98749A (en) Heterocycle compounds and method for their preparation
AU5087393A (en) Therapeutic compositions and methods for inhibiting il-8-mediated inflammation
GB9122886D0 (en) Pharmaceutical composition and method
AU6441596A (en) Therapeutic preparation and method